Associate Professor at the Department of Pediatrics, University of Montreal, Montreal, Canada.
Canada
Dr. Philippe Campeau is a distinguished medical geneticist renowned for his expertise in neurodevelopmental disorders and skeletal dysplasias. With extensive training from institutions in Canada and the United States, including Laval University and Baylor College of Medicine, Dr. Campeau has led groundbreaking research in identifying disease genes using next-generation sequencing technologies, notably contributing to understanding conditions like DOORS syndrome and Genitopatellar syndrome. As a Medical Geneticist at CHU Sainte-Justine and Shriners Canada in Montreal, coupled with his roles as an Associate Professor of pediatrics at the University of Montreal, he bridges clinical practice and research, emphasizing translational approaches.
Dr. Philippe Campeau, a distinguished medical geneticist, has made significant contributions to both clinical practice and research in the field of genetic disorders. Educated extensively in Canada and the United States, Dr. Campeau obtained his MD from Laval University and completed his residency in Medical Genetics at McGill University. His postdoctoral fellowship at Baylor College of Medicine in Human Genetics further honed his expertise. Currently serving as a Medical Geneticist at CHU Sainte-Justine and Shriners Canada in Montreal, he is also an Associate Professor at the University of Montreal, where he actively contributes to the education of future medical professionals.
Dr. Campeau's research focuses primarily on neurodevelopmental disorders and skeletal dysplasias. Through his directed research lab, he has elucidated the genetic underpinnings of various conditions, such as DOORS syndrome and Genitopatellar syndrome, significantly advancing our understanding of these rare disorders. His work on identifying disease genes through next-generation sequencing techniques has been pivotal in unveiling the molecular basis of Mendelian diseases, establishing him as an expert in the field.
With a keen interest in epigenetic diseases, Dr. Campeau has spearheaded projects aimed at characterizing these disorders to identify signaling pathways for potential therapeutic interventions. Notably, his investigations into fibronectin mutations causing spondylometaphyseal dysplasia have provided crucial insights into disease mechanisms and potential therapeutic targets, showcasing his commitment to translational research.
Beyond his research endeavors, Dr. Campeau has played a pivotal role in fostering collaboration between clinicians and scientists through initiatives such as the Canadian Rare Diseases Models and Mechanisms Network. This network facilitates the study of rare disease genes in model organisms, fostering interdisciplinary research aimed at advancing treatments for rare diseases.
Dr. Campeau's contributions have been widely recognized, evident from his numerous awards and honors, including the prestigious Joe Doupe Young Investigator Award from the Canadian Society for Clinical Studies. His dedication to advancing medical genetics and improving patient care underscores his stature as a leading figure in the field, with a profound impact on both research and clinical practice.
Department of Pediatrics, University of Montreal, Montreal, Canada
Shriners Hospital Canada, Montreal, Canada.
Medical Genetics Division, Department of Pediatrics, CHU Sainte-Justine, Montreal, Canada
Department of Pediatrics, University of Montreal, Montreal, Canada.
Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Lab of Dr. Brendan Lee, Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine, TX, USA
2013
2008
2008